Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene therapy
Biotech
Opus sets sights on FDA talks after posting gene therapy data
Opus Genetics shared data on its gene therapy in kids with an ultrarare eye disease, setting the biotech up to talk to the FDA about the next steps.
Nick Paul Taylor
Sep 30, 2025 9:15am
Biogen discontinues all AAV gene therapy work
Sep 26, 2025 11:04am
Arena BioWorks, 19 months after splashy launch, lays off staff
Aug 22, 2025 10:05am
Fierce Pharma
Sarepta extends $700M debt to 2030 amid Elevidys uncertainty
Aug 21, 2025 10:52am
Krystal discontinues melanoma study after FDA's Replimune rebuff
Aug 21, 2025 10:50am
Rocket's gene therapy free from FDA hold
Aug 20, 2025 10:40am
